日本第一生命旗下公司提出收购澳大利亚投资管理商 Challenger 报价 79.4 亿澳元
悉尼——据路透社报道，澳大利亚投资管理公司 Challenger 表示，日本第一生命控股旗下的 TAL Daiichi Life Australia 已提交一份指示性收购提案，拟收购其尚未持有的 Challenger 逾 79% 的股份，对 Challenger 的估值约为 79.4 亿澳元（约合 55.3 亿美元）。
提案出价为每股 11.80 澳元，较 Challenger 上周五的收盘价溢价 19.8%。TAL 目前持有 Challenger 约 20.36% 的股份。Challenger 表示，这份提案附带多项条件，包括尽职调查圆满完成，公司董事会正在审议这份指示性报价。
Challenger 是澳大利亚主要的退休收入与年金产品提供商之一，总部位于 Sydney。该交易目前仍处于提案阶段，最终是否达成取决于尽职调查结果与董事会审议。
Japan's Daiichi Life Unit Bids A$7.94 Billion for Australia's Challenger
SYDNEY — TAL Daiichi Life Australia, a unit of Japan's Daiichi Life Holdings, has submitted an indicative proposal to buy the more than 79 percent of Australian investment manager Challenger that it does not already own, Challenger said, in a deal valuing the company at about A$7.94 billion (US$5.53 billion), according to Reuters.
The proposal offers A$11.80 per share, a premium of 19.8 percent to Challenger's closing price last Friday. TAL currently holds about 20.36 percent of Challenger. Challenger said the proposal is subject to a number of conditions, including satisfactory completion of due diligence, and that its board is considering the indicative offer.
Challenger, headquartered in Sydney, is one of Australia's leading providers of retirement-income and annuity products. The bid remains at the proposal stage, and whether it proceeds will depend on due diligence and the board's assessment.
来源：GSM·美国（原文链接）
图片来源：澳大利亚Sydney中央商务区。照片：Wikimedia Commons（CC BY 4.0）。Sydney's central business district, Australia. Photo: Wikimedia Commons (CC BY 4.0).
GSM Global · 本篇英文版 English edition of this story
